AiCure’s CEO offers an inside look at how the company is using AI, computer vision, and its new WeightVerify™ platform to tackle one of healthcare’s biggest challenges: keeping patients on therapy and reliably tracking outcomes in obesity, diabetes, cardiovascular disease, and GLP‑1 programs.
Read the Forbes article, The AI Company Transforming Medication Adherence and Weight Loss, to learn how AICure is transforming medication adherence, weight‑loss programs, and clinical trial operations, not just in theory but in regulated, real‑world settings.